These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 104154)

  • 21. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
    Saucier JM; Yu J; Gaikwad A; Coleman RL; Wolf JK; Smith JA
    J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy of ovarian cancer: past and present.
    Young RC
    Semin Oncol; 1975 Sep; 2(3):267-76. PubMed ID: 827024
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of advanced ovarian cancer with cis-dichlorodiammine platinum in combination with cyclophosphamide. An E.C.O.G. pilot study.
    Israel L; Aguilera J; Breau JL
    Am J Clin Oncol; 1983 Feb; 6(1):85-9. PubMed ID: 6682285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tumors of ovary and testis (author's transl)].
    De Jager R
    Rev Med Brux; 1980 May; 1(5):315-20. PubMed ID: 6258206
    [No Abstract]   [Full Text] [Related]  

  • 25. Further experience with chemotherapy in the Dunning prostatic adenocarcinoma.
    Block NL; Camuzzi F; Stover B; Claflin A; Troner M; Politano VA
    Trans Am Assoc Genitourin Surg; 1978; 70():57-9. PubMed ID: 753023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Delayed platinum diamminodichloride toxicity in patients with germ tumors of the gonads].
    Germà Lluch JR; Izquierdo Font A; Barnadas Molins A; Arcusa Lanza MA; Ojeda González B
    Med Clin (Barc); 1984 Mar; 82(10):442-5. PubMed ID: 6538917
    [No Abstract]   [Full Text] [Related]  

  • 27. Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.
    Williams CJ; Stevenson KE; Buchanan RB; Whitehouse JM
    Cancer Treat Rep; 1979; 63(11-12):1745-53. PubMed ID: 393378
    [No Abstract]   [Full Text] [Related]  

  • 28. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
    Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of cisplatin nephrotoxicity in cancer: adjusting the dosage with a computerized chrono-pump].
    Gestin-Boyer C; René C; Cupissol D; Tep A; Bressolle F; Bres J; Brun S; Serrou B; Pujol H
    C R Seances Soc Biol Fil; 1989; 183(3):263-8. PubMed ID: 2532561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is adjuvant chemotherapy following retroperitoneal lymph node dissection for nonseminomatous testis cancer necessary?
    Donohue JP; Einhorn LH; Williams SD
    Urol Clin North Am; 1980 Oct; 7(3):747-56. PubMed ID: 6161464
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemotherapy in advanced ovarian cancer.
    Smith JP; Rutledge FN
    Natl Cancer Inst Monogr; 1975 Oct; 42():141-3. PubMed ID: 825776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combined therapy of ovarian cancer (author's transl].
    Vahrson H; Wolf A; Jankowski R
    Geburtshilfe Frauenheilkd; 1977 Feb; 37(2):131-8. PubMed ID: 838261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma.
    Decker DG; Fleming TR; Malkasian GD; Webb MJ; Jeffries JA; Edmonson JH
    Obstet Gynecol; 1982 Oct; 60(4):481-7. PubMed ID: 6889714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cisplatin].
    Millá A; Grau JJ; Estapé J
    Med Clin (Barc); 1983 Feb; 80(6):283-8. PubMed ID: 6345956
    [No Abstract]   [Full Text] [Related]  

  • 36. Reversal of hypertrophic osteoarthropathy after chemotherapy for bronchogenic carcinoma.
    Evans WK
    J Rheumatol; 1980; 7(1):93-7. PubMed ID: 7354475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuropathies in cancer patients during chemotherapy with platinum preparations].
    Perevodchikova NI; Zavalishin IA; Adartseva LS; Sloka SA; Orel NF; Gorbunova VA; Brovtsyn VK
    Sov Med; 1991; (1):79-81. PubMed ID: 1862396
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Apropos of an experience with the polychemotherapy of cancer].
    Dargent M; Pommatau E; Brunat M
    Poumon Coeur; 1968; 24(1):39-45. PubMed ID: 4298530
    [No Abstract]   [Full Text] [Related]  

  • 40. DNA adducts induced by platinum drug chemotherapeutic agents in human tissues.
    Poirier MC; Shamkhani H; Reed E; Tarone RE; Gupta-Burt S
    Prog Clin Biol Res; 1992; 374():197-212. PubMed ID: 1620704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.